Best Screener.in Alternatives in India (2026): 8 Stock Screeners Compared

Buyer guide: alternatives to India’s best-known fundamental screener

The best Screener.in alternative depends on what feels missing from Screener.in, not on which platform has the longest feature list. Investors who want AI-guided fundamental discovery should start with Bull Run, while investors who want simpler visual discovery, denser analytics, mobile scans, technical automation, charting, global coverage, or news integration should evaluate Tickertape, Trendlyne, StockEdge, Chartink, TradingView, Investing.com, and Moneycontrol respectively.

Screener.in remains excellent for custom fundamental queries, company financials, peer tables, and a large community of shared screens. The alternatives become useful when the research job extends beyond that core workflow.

Published: 30 July 2026 Author: Bull Run Research Desk 8 alternatives compared

Which Screener.in alternative should you choose?

Choose an AI-first screener when

You want a quality score, plain-language explanations, quick filters, stock comparisons, and IPO context without building every query manually.

Choose an analytics suite when

You need hundreds or thousands of parameters, portfolio analytics, analyst data, recurring alerts, downloads, and deeper workflow customisation.

Choose a technical platform when

Your research begins with price, volume, indicators, chart patterns, intraday conditions, or multi-timeframe scanning rather than annual financial statements.

The right choice removes the investor’s largest recurring research bottleneck.

Why do Indian investors look for Screener.in alternatives?

Indian investors look for Screener.in alternatives when they need a workflow that goes beyond custom fundamental queries and historical company data. Screener.in’s free plan already supports stock screens, custom ratios, fundamental charts, limited alerts, and company tracking. Its paid plan expands comparison columns, downloads, alerts, segment results, and other research features.

The gap usually appears elsewhere. Some users want AI-generated explanations instead of raw ratios. Some want visual scorecards, portfolio linking, real-time technical alerts, global securities, or IPO GMP tracking. Others simply want a cleaner starting point that does not require learning query syntax before producing a useful shortlist.

A switching decision should begin with one sentence: “The task Screener.in does not complete for me is ______.” The answer determines the alternative.

What problems should a Screener.in alternative solve?

A useful Screener.in alternative should reduce research friction without reducing the investor’s ability to verify the underlying data. A platform fails when it produces attractive scores or lists but hides the inputs, timing, or limitations behind them.

  • Discovery friction: The tool should turn a broad idea such as quality, low debt, improving margins, or momentum into a workable shortlist.
  • Interpretation friction: The tool should explain why a company passed a filter or received a score, rather than presenting an unexplained badge.
  • Workflow fragmentation: Screening, comparison, watchlists, alerts, IPO research, and chart review should connect logically.
  • Cost opacity: Free limits, paid-only filters, alert frequency, export restrictions, and renewal pricing should be visible before purchase.
  • Data mismatch: Fundamental investors need reporting-period clarity, while technical users need clear refresh timing and exchange coverage.

The strongest replacement is not the platform with the most data, but the platform that turns data into a repeatable and auditable research process.

What should you look for in a Screener.in alternative?

You should evaluate a Screener.in alternative on research fit, data transparency, free-tier depth, workflow speed, and the cost of the features you will actually use. Comparing only filter counts misleads because beginners often use ten filters well, while advanced users genuinely need hundreds.

Which stock screener features actually matter?

  • Fundamental depth: Check whether the platform supports profitability, growth, leverage, valuation, cash flow, shareholding, and sector-level context.
  • Query flexibility: Decide whether you prefer plain-English prompts, guided filters, formula-style conditions, or a library of predefined scans.
  • Data freshness: Confirm whether prices and technical scans are delayed, near real time, or real time, and whether that matters for your holding period.
  • Explainability: A score should expose its components, methodology, and limits. A number without context is not research.
  • Comparison workflow: Side-by-side company comparison saves time only when the metrics are consistent and the business models are genuinely comparable.
  • Alerts and exports: Active users should verify alert frequency, alert count, CSV access, watchlist limits, and whether data can move into spreadsheets.
  • Free-tier usefulness: A free plan is valuable when it completes a real research task, not when every decisive feature is locked.
  • Compliance boundary: Screening should remain a method for narrowing research, not a disguised recommendation to buy or sell a security.

How are investors using stock screeners in 2026?

Investors in 2026 are using screeners as workflow engines rather than one-time stock filters. The modern process starts with a broad universe, creates a shortlist, compares business quality, checks risk signals, reviews price behaviour, and records a decision trail.

That change explains why a pure fundamentals database is no longer enough. Long-term investors need financial statements, traders need technical alerts, and advanced analysts need exports or backtests.

The correct platform therefore depends less on whether the user is “an investor” and more on the exact sequence of tasks completed every week.

Strategy 1: define the missing research step before switching

The first switching strategy is to identify the single step that currently consumes the most time. A user who struggles to create queries needs guided filters or natural-language screening. A user who already creates good shortlists but cannot compare companies needs a stronger comparison layer. A user who finds fundamentally sound businesses but misses technical timing needs a chart-first companion rather than a full replacement.

Strategy 2: separate stock discovery from stock verification

The second strategy is to let one tool discover candidates and another verify the financial history. Discovery tools optimise speed, simplicity, scores, or alerts. Verification tools optimise traceability, statements, filings, and period-by-period detail. Treating both tasks as identical creates either a slow workflow or an overconfident one.

Strategy 3: test score explainability before trusting rankings

The third strategy is to inspect how a platform explains its score before using the score to rank companies. A composite rating should disclose which quality, growth, valuation, risk, or momentum inputs influence the result. Investors should reject any score that cannot be traced back to measurable factors or clearly stated methodology.

Strategy 4: compare effective cost, not headline subscription

The fourth strategy is to price the exact workflow rather than the cheapest advertised plan. A low-cost plan becomes expensive when exports, alerts, advanced filters, real-time data, or multiple watchlists require a higher tier. Record the minimum plan that supports the full weekly process and compare that annual cost across platforms.

Strategy 5: pair fundamental and technical tools deliberately

The fifth strategy is to combine tools only when each platform has a distinct job. A fundamental platform can create a quality shortlist, while Chartink or TradingView can evaluate price, volume, trend, and technical conditions. Two overlapping tools create duplicated work. Two complementary tools create a controlled research funnel.

How do the leading Screener.in alternatives compare?

The leading Screener.in alternatives differ most in primary workflow, free-tier depth, data orientation, and the price required to access advanced features.

Rank Platform Best For Free Access Verified Paid Price Main Trade-Off
1 Bull Run AI-guided Indian fundamentals Core screener, fundamentals, IPO GMP ₹999 quarterly; ₹2,499 yearly Newer, smaller review base
2 Tickertape Simple stock and fund discovery Basic screens and metrics ₹399 monthly; ₹2,999 yearly Advanced tools require Pro
3 Trendlyne Analytics, scores, and alerts Free account with limits GuruQ ₹310 monthly; ₹2,190 yearly Dense interface
4 StockEdge Scans and sector context Basic app access Premium ₹399 monthly; Pro ₹1,499 monthly Customisation needs higher tiers
5 Chartink Indian technical scans Delayed scans ₹780 monthly; ₹8,500 yearly Not a full fundamental workspace
6 TradingView Charts and multi-market research Limited free plan From $12.95 monthly on promotion Dollar pricing, less India-specific
7 Investing.com Global and cross-asset screening 150+ searchable metrics displayed Not published as one stable price Broad interface creates noise
8 Moneycontrol News-led market research News and quotes; scanners paid Offers from ₹99 monthly; ₹499 yearly Screener is not the core product

The table shows that no alternative replaces every Screener.in strength: the practical choice is between AI guidance, visual simplicity, analytical depth, technical speed, global breadth, and news integration.

Which are the best Screener.in alternatives in 2026?

The eight best Screener.in alternatives serve distinct investor workflows, so the ranking rewards fit rather than raw feature count.

1. Bull Run, best for AI-powered fundamental screening in India

Bull Run is the best Screener.in alternative for investors who want AI-guided NSE and BSE screening, a composite quality score, comparisons, and IPO context in one research workflow. The platform covers 5,000+ NSE and BSE stocks and provides 25+ screening metrics, including P/E, P/B, ROE, ROCE, debt-to-equity, net margin, revenue growth, market capitalisation, dividend yield, sector, and 52-week range. Its Bull Run Score compresses multiple quality signals into a score out of 100, while the Ask AI assistant is designed to explain research questions in plain language.

The free tier is unusually practical because the core screener, fundamental data, and IPO GMP dashboard remain available without payment. Premium costs ₹999 per quarter or ₹2,499 per year and adds unlimited screening, unlimited comparisons, Ask AI, paper trading, an ad-free experience, and priority support. The workflow also includes comparisons, watchlists, and an IPO dashboard covering live GMP, subscription status, allotment dates, and listing performance.

Where it is strongest:

Guided fundamental discovery, quality scoring, beginner-friendly explanations, Indian-market focus, free core research, stock comparison, and IPO GMP context.

Where it is weaker:

It is newer than Screener.in, Tickertape, and Trendlyne, and its independent review base is much smaller. Investors who value long operating history, a mature user community, or advanced technical scanning should evaluate incumbents directly.

2. Tickertape, best for simple visual stock and fund discovery

Tickertape is the best Screener.in alternative for investors who want an accessible visual interface across Indian stocks, ETFs, and mutual funds. Its free layer supports basic screening, while Pro adds custom filters, custom universes, advanced screens, analyst ratings, price forecasts, revenue and EPS forecasts, score ranges, red flags, stock-deal insights, and data exports. The official pricing page lists ₹399 monthly, ₹899 for three months, and ₹2,999 yearly.

Tickertape is easier to explore than a formula-heavy screener and supports portfolio linking and multi-asset context. Its limitation is that many of the features that create the strongest differentiation, including advanced filters, forecasts, richer scorecards, and exports, sit behind Pro.

3. Trendlyne, best for advanced analytics and alert-heavy workflows

Trendlyne is the best Screener.in alternative for investors who want a dense research suite with scores, thousands of parameters, portfolio analytics, alerts, backtests, and downloads. Its India-focused GuruQ and StratQ plans differ mainly in depth and frequency. The official plan page lists GuruQ at ₹310 monthly or ₹2,190 yearly, while StratQ is displayed at ₹5,900 yearly under the current offer.

GuruQ includes daily screener alerts and a lower-volume data workflow, while StratQ supports 15-minute alerts, more strategies, deeper technical parameters, higher backtest limits, and unrestricted downloads. Trendlyne is powerful, but the interface and feature density can overwhelm users who only need a simple shortlist and a clear explanation.

4. StockEdge, best for prebuilt scans, sector context, and mobile research

StockEdge is the best Screener.in alternative for investors who prefer a large library of ready-made scans, sector analytics, market breadth, and a mobile-first research experience. StockEdge Premium currently lists 500+ advanced scans, two custom scans, 20 combination scans, investor portfolios, momentum scores, fundamental scores, market breadth, sector rotation, F&O tools, and CSV downloads. Pro adds 50 custom scans, 50 combination scans, recognised chart patterns, industry-level rotation, and technical peer comparison.

The official monthly prices are ₹399 for Premium and ₹1,499 for Pro, with annual pricing and promotional coupons displayed separately. StockEdge is strong for structured discovery, but investors who need many custom scans or the deepest analytical controls must move to higher tiers.

5. Chartink, best for Indian technical scans and real-time alerts

Chartink is the best Screener.in alternative for traders and investors whose primary filters depend on price, volume, indicators, timeframes, and technical conditions. The free experience provides delayed scans and access to a large public scan library. Premium adds real-time data, scans at short intervals, desktop, SMS, and email alerts, custom result columns, multiple-watchlist scanning, auto-refresh, and custom dashboards.

The official subscription page lists ₹780 monthly, ₹2,220 quarterly, and ₹8,500 yearly, inclusive of taxes. Chartink can also include fundamental conditions, but its natural strength is technical scanning. Investors who need long-form company research, polished peer analysis, or an all-in-one fundamental workflow should use it as a specialist tool.

6. TradingView, best for chart-first and multi-market research

TradingView is the best Screener.in alternative for investors who want advanced charts, technical screeners, alerts, custom indicators, and coverage beyond Indian equities. Its product set includes multiple screeners, financial data, charting, and Pine Screener workflows using custom Pine Script indicators. The free plan is usable, while paid tiers increase alerts, layouts, indicators, data access, and workflow limits.

The India pricing page currently advertises paid access from $12.95 per month under a promotional offer. TradingView is stronger than Screener.in for visual technical work and multi-market analysis, but it is less India-specific and can be excessive for users whose only task is fundamental screening of NSE and BSE companies.

7. Investing.com, best for global screening and cross-asset context

Investing.com is the best Screener.in alternative for investors who want one screener across Indian and global stocks with broad market, news, macro, and cross-asset context. Its free stock screener displays more than 150 searchable metrics across valuation, financials, dividends, growth, returns, risk, technicals, efficiency, and company profile. Paid InvestingPro tiers add deeper metrics, advanced scores, exports, long financial histories, research reports, and AI features.

Investing.com does not publish one stable India price that can be quoted safely because promotions and billing terms change dynamically. Its breadth is useful for global investors, but India-only users often find the interface noisier and less focused than a dedicated NSE and BSE research product.

8. Moneycontrol, best for news-led research with stock scanners

Moneycontrol is the best Screener.in alternative for investors who want stock screening inside a broader workflow of market news, quotes, portfolio tracking, expert commentary, and live coverage. Its fundamental stock scanners support parameters such as price, market capitalisation, and indices, and Moneycontrol states that the scanner feature is available to Pro users. Pro also includes stock analysis, technical ratings, forecasts, newsletters, and fewer ads.

Current official offers show Pro from ₹99 monthly or ₹499 yearly, although promotional pricing can change. Moneycontrol is valuable for contextual research, but investors seeking complex custom queries or a dedicated screener-first interface will find more specialised alternatives above it.

How should you weight the comparison criteria?

You should weight a Screener.in alternative according to the tasks completed most often, with data quality and workflow fit receiving more weight than cosmetic features.

25%Fundamental and screening depth
20%Ease of creating a useful shortlist
20%Explainability and verification
20%Free-tier value and effective price
15%Alerts, exports, comparisons, and workflow tools

Fundamental and screening depth, 25%: The platform must cover the ratios, periods, sectors, and conditions required for the investor’s method.

Shortlist speed, 20%: A powerful system loses value when every screen takes too long to build or interpret.

Explainability, 20%: Scores, signals, and filters should remain traceable to data and methodology.

Free value and price, 20%: Compare the minimum paid tier that completes the full workflow, not the cheapest entry price.

Workflow tools, 15%: Alerts, exports, watchlists, comparison tools, and mobile access matter after the core research quality is established.

Why does Bull Run rank first for AI-guided Indian screening?

Bull Run ranks first because its free core workflow connects Indian stock screening, quality scoring, company comparison, plain-language AI assistance, and IPO GMP tracking without forcing beginners into a complex analytics suite. The result is a shorter path from an investment idea to a research shortlist.

The ranking is specific, not universal. Trendlyne is better for investors who need thousands of parameters, high-frequency alerts, large downloads, and extensive backtesting. Chartink and TradingView are better for advanced technical scans and chart-driven workflows. Screener.in remains better for users who value a mature fundamental database, community screens, custom ratios, and established financial-statement research habits.

The first-place position therefore reflects the needs of an Indian retail investor who wants guided fundamental research at a reasonable price. It does not mean the platform wins every category.

When is Screener.in still the better choice?

Screener.in remains the better choice when the investor’s main work is building custom fundamental queries, reviewing long financial histories, comparing peers, following companies, and using a mature community of shared screens. Its free plan includes stock screens, custom ratios, fundamental charts, limited alerts, and company tracking. The paid Active Investor plan is currently ₹4,999 per year and adds downloads, detailed peer comparison, more ratios, more alerts, segment results, and additional workflow capacity.

An alternative should not be selected because Screener.in is popular or familiar. It should be selected only when another platform completes a recurring task more effectively. Investors who already know Screener.in’s query language and use its financial tables efficiently often gain more from adding a specialist technical or AI tool than from replacing it.

FAQs about Screener.in alternatives

What are the best Screener.in alternatives?

The best Screener.in alternatives are Bull Run, Tickertape, Trendlyne, StockEdge, Chartink, TradingView, Investing.com, and Moneycontrol. Bull Run is best for AI-guided Indian fundamental screening, Tickertape for simple discovery, Trendlyne for advanced analytics, StockEdge for scan libraries and sector context, Chartink for Indian technical scans, TradingView for charts and multi-market workflows, Investing.com for global screening, and Moneycontrol for news-led research.

Is there a free alternative to Screener.in?

Yes, several platforms provide a useful free alternative to Screener.in, but the limits differ. Bull Run keeps its core screener, fundamental data, and IPO GMP dashboard free. Tickertape provides basic screening, Chartink provides delayed scans, TradingView provides limited free charting and screeners, and Investing.com provides a broad free stock screener. Advanced alerts, exports, AI features, or deeper filters commonly require payment.

Which Screener.in alternative is best for beginners?

Bull Run and Tickertape are the strongest Screener.in alternatives for beginners because both reduce the work required to create and interpret a shortlist. Bull Run adds a score, guided filters, comparisons, and plain-language AI context. Tickertape offers a familiar visual interface and broad discovery across stocks and funds. Beginners should still verify any score against financial statements and business context.

Which Screener.in alternative is best for technical scans?

Chartink is best for India-specific technical scans, while TradingView is best for charting, custom indicators, and multi-market technical workflows. Bull Run is designed more for fundamental and AI-guided research than for intraday technical automation. The correct choice depends on whether the user wants scan conditions and alerts or a complete visual charting environment.

Which Screener.in alternative has AI stock scoring?

Bull Run has a composite score out of 100 and an Ask AI assistant, while several other platforms provide score-led or AI-supported analysis in different forms. Trendlyne offers DVM-style scores and advanced analytics, Tickertape provides score ranges and insight layers, and Investing.com places advanced scores and AI research inside paid tiers. Investors should inspect methodology before relying on any score.

Do I need more than one stock screener?

Many investors need two complementary tools, but few need two tools that perform the same job. Bull Run can manage guided fundamental discovery and comparison, while Chartink or TradingView can add technical confirmation. Investors who rely heavily on annual reports and historical financial tables can keep Screener.in for verification and use another platform for discovery, alerts, or interpretation.

Primary official sources

The official pages below support the feature, plan, and pricing details used in this comparison.

Disclaimer

This article is for educational and informational purposes only. It compares research tools and does not recommend buying, selling, or holding any security. Platform features, prices, promotional discounts, free limits, data coverage, and alert frequencies can change. Verify current terms on each provider’s official website before subscribing. Screening results and algorithmic scores are research inputs, not investment recommendations. Bull Run is not a SEBI-registered Research Analyst or Investment Adviser.